Shares of Moderna (NASDAQ: MRNA) were rebounding somewhat on Thursday after several days of declines. The stock was up 4.6% as of 10:59 a.m. EDT today.
Moderna actually had more bad news today. Finland joined Denmark and Sweden in pausing the use of the company’s COVID-19 vaccine for some individuals due to concerns about a rare heart inflammation issue. Finland’s pause applies to men under age 30, the demographic with the highest risk for the cardiovascular problems.